Frontiers in Physiology (Jun 2022)
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential
- Jens Spiesshoefer,
- Jens Spiesshoefer,
- Binaya Regmi,
- Matteo Maria Ottaviani,
- Florian Kahles,
- Alberto Giannoni,
- Chiara Borrelli,
- Claudio Passino,
- Vaughan Macefield,
- Vaughan Macefield,
- Michael Dreher
Affiliations
- Jens Spiesshoefer
- Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany
- Jens Spiesshoefer
- Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy
- Binaya Regmi
- Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany
- Matteo Maria Ottaviani
- Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy
- Florian Kahles
- Department of Cardiology and Vascular Medicine, University Hospital RWTH Aachen, Aachen, Germany
- Alberto Giannoni
- Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy
- Chiara Borrelli
- Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy
- Claudio Passino
- Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy
- Vaughan Macefield
- Human Autonomic Neurophysiology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
- Vaughan Macefield
- Department of Anatomy and Physiology, University of Melbourne, Melbourne, VIC, Australia
- Michael Dreher
- Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany
- DOI
- https://doi.org/10.3389/fphys.2022.919422
- Journal volume & issue
-
Vol. 13
Abstract
GRAPHICAL ABSTRACT
Keywords
- sympathetic drive
- chronic lung disease
- cardiovascular stress
- autonomic nervous system
- vagal activity
